Obstetrics & Gynecology:
The Frequency and Complication Rates of Hysterectomy Accompanying Cesarean Delivery
Shellhaas, Cynthia S. MD, MPH1; Gilbert, Sharon MS, MBA13; Landon, Mark B. MD1; Varner, Michael W. MD2; Leveno, Kenneth J. MD3; Hauth, John C. MD4; Spong, Catherine Y. MD14; Caritis, Steve N. MD5; Wapner, Ronald J. MD6; Sorokin, Yoram MD7; Miodovnik, Menachem MD8; O’Sullivan, Mary J. MD9; Sibai, Baha M. MD10; Langer, Oded MD11; Gabbe, Steven G. MD12; for the Eunice Kennedy Shriver National Institutes of Health and Human Development (NICHD) Maternal–Fetal Medicine Units Network (MFMU)
From the Departments of Obstetrics and Gynecology at the 1Ohio State University, Columbus, Ohio; 13the George Washington University Biostatistics Center, Washington, DC; 2University of Utah, Salt Lake City, Utah; 3University of Texas Southwestern Medical Center, Dallas, Texas; 4University of Alabama at Birmingham, Birmingham, Alabama; 5University of Pittsburgh, Pittsburgh, Pennsylvania; the 14Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland; 6Thomas Jefferson University, Philadelphia, Pennsylvania; 7Wayne State University, Detroit, Michigan; 8University of Cincinnati, Cincinnati, Ohio; 9University of Miami, Miami, Florida; 10University of Tennessee, Memphis, Tennessee; 11University of Texas at San Antonio, San Antonio, Texas; 12and Vanderbilt University, Nashville, Tennessee.
*For the other members of the NICHD MFMU who participated in this study, see the Appendix online at http://links.lww.com/A1382.
Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD21410, HD21414, HD27860, HD27861, HD27869, HD27905, HD27915, HD27917, HD34116, HD34122, HD34136, HD34208, HD34210, and HD36801).
The authors thank Francee Johnson, BSN, and Julia Gold, RN, for protocol development and coordination between clinical research centers and Elizabeth Thom, PhD, for protocol/data management and statistical analysis.
Presented at the Annual Meeting of the Society for Maternal-Fetal Medicine, New Orleans, Louisiana, January 14–19, 2002.
Corresponding author: Cynthia Shellhaas, MD, MPH, Room 550, 935 West 12th Avenue, Division of Maternal-Fetal Medicine, The Ohio State University College of Medicine, Columbus, OH 43210; e-mail: Cynthia.firstname.lastname@example.org.
Financial Disclosure The authors did not report any potential conflicts of interest.
OBJECTIVE: To estimate the frequency, indications, and complications of cesarean hysterectomy.
METHODS: This was a prospective, 2-year observational study at 13 academic medical centers conducted between January 1, 1999, and December 31, 2000, on all women who underwent a hysterectomy at the time of cesarean delivery. Data were abstracted from the medical record by study nurses. The outcomes included procedure frequency, indications, and complications.
RESULTS: A total of 186 cesarean hysterectomies (0.5%) were performed from a cohort of 39,244 women who underwent cesarean delivery. The leading indications for hysterectomy were placenta accreta (38%) and uterine atony (34%). Of the hysterectomy cases with a diagnosis recorded as accreta, 18% accompanied a primary cesarean delivery, and 82% had a prior procedure (P<.001). Of the hysterectomy cases with atony recorded as a diagnosis, 59% complicated primary cesarean delivery, whereas 41% had a prior cesarean (P<.001). Major maternal complications of cesarean hysterectomy included transfusion of red blood cells (84%) and other blood products (34%), fever (11%), subsequent laparotomy (4%), ureteral injury (3%), and death (1.6%). Accreta hysterectomy cases were more likely than atony hysterectomy cases to require ureteral stents (14% compared with 3%, P=.03) and to instill sterile milk into the bladder (23% compared with 8%, P=.02).
CONCLUSION: The rate of cesarean hysterectomy has declined modestly in the past decade. Despite the use of effective therapies and procedures to control hemorrhage at cesarean delivery, a small proportion of women continue to require hysterectomy to control hemorrhage from both uterine atony and placenta accreta.
LEVEL OF EVIDENCE: II
Cesarean delivery is the most common major operation performed in the United States,1 and hysterectomy may be a life-saving adjunctive procedure. Cesarean hysterectomy occurs in the United States at a reported incidence of 7.0–8.3 per 1,000 cesarean deliveries2,3 and 1.02–1.55 per 1,000 total births.2–5 During the early twentieth century, cesarean hysterectomy was performed primarily to avoid postoperative infection and massive blood loss.6 As the safety of cesarean delivery improved, it then became an accepted method of sterilization.7–11 At present, most cesarean hysterectomies are emergent and are performed to control hemorrhage.
Studies of cesarean hysterectomy are predominantly single-center reviews compiled over many years or decades.7–9 As surgical indications and techniques have evolved over time, these studies may have limited relevance to modern practice. The purpose of this analysis was to estimate the frequency of cesarean hysterectomy, its indications, and associated complications in a contemporary, large, multicenter, prospective, observational study.
MATERIALS AND METHODS
The Cesarean Registry was a prospective, observational study of the Maternal-Fetal Medicine Units Network of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. It was designed to assess specific contemporary issues related to cesarean delivery and was conducted at 13 academic medical centers between January 1, 1999, and December 31, 2000. Approval from the institutional review board at each participating center was obtained. The labor and delivery logbook or computer database at each participating center was screened daily to identify all cesarean deliveries. Medical records were reviewed by trained study nurses. Demographic data, details of the obstetric history, and intrapartum and postpartum information, including primary and secondary procedure indications, subsequent complications, and concomitant operative procedures, were recorded. For this study, all women who underwent a hysterectomy at the time of delivery were examined. Data forms were entered at each clinical center and transmitted weekly to the data-coordinating center at the George Washington University Biostatistics Center, where they were uploaded to a mainframe computer and merged with the existing database. The data were edited and corrections entered on a regular basis for missing, out of range, and inconsistent values.
The term “hemorrhage” was assigned whenever any transfusion products were given. Estimated blood loss from the operative note was not collected because of its subjectivity. Instead, the change in hematocrit from preoperative value to the lowest recorded value was used as a surrogate measure. Atony was considered present in any woman who received oxytocic agents, including methylergonovine maleate (Methergine, Novartis Pharmaceutical Corp., East Hanover, NJ), carboprost tromethamine (Hemabate, Pfizer, New York, NY), or oxytocin, for therapeutic rather than prophylactic indications. Placenta accreta was defined clinically as a placenta adherent to the uterine wall that could not be easily separated. Cases of percreta and increta were grouped with placenta accreta. Postoperative fever was defined as any temperature 100.4°F or more or 38°C or more.
Categorical variables were compared using the χ2 test or the Mantel-Haenszel test of trend as appropriate.12 The 95% confidence intervals for single-sample binomial interval estimation were calculated using the Blyth-Still-Casella method.13 A nominal two-tailed P value of less than 0.05 was considered to indicate statistical significance; no adjustments were made for multiple comparisons. We used SAS software (SAS Institute, Inc., Cary, NC) and StatXact (Cytel Software, Cambridge, MA) for analyses.
There were a total of 184,387 deliveries during the study period, of which 39,283 women underwent cesarean delivery, with 186 women having cesarean hysterectomies. The overall cesarean delivery rate was 21.3%. For this analysis, the hysterectomy cohort was obtained after removing 11 patients due to missing data; the hysterectomy could not be confirmed. Women (n=28) who underwent postcesarean hysterectomy (laparotomy performed after the original procedure) were excluded as well. Information about this subset in terms of time interval between cesarean delivery and hysterectomy, complications and concomitant procedures, or indication for hysterectomy was not collected. This resulted in a total of 186 (0.5%) cesarean hysterectomies performed in a cohort of 39,244 women who underwent cesarean delivery, for a frequency of 1 in 211 cesareans. Although not statistically significant (P=.12), there was a variation in incidence of cesarean hysterectomies among the 13 academic centers, with a range of 1 in 530 (0.2%) to 1 in 119 (0.8%) cesarean deliveries.
The demographic characteristics of the hysterectomy cohort are detailed in Table 1. Interestingly, 46% of hysterectomies occurred in patients with gestational ages less than 37 weeks. Nearly one half of these (49%) preterm deliveries were done with a cesarean indication of placenta previa; 36% of the preterm deliveries were primary, and 64% were repeat cesarean deliveries. The most common primary indications for hysterectomy in this subset of preterm deliveries were accreta (54%) and atony (20%).
The primary indications for cesarean delivery among all women undergoing cesarean hysterectomy are listed in Table 2. A history of a prior cesarean delivery was a risk factor for hysterectomy. A trend was seen for the risk of hysterectomy as the number of prior cesareans increased, from 0.3% without a prior cesarean to 2.9% with three or more prior procedures (P<.001 for trend).
The primary indications for hysterectomy are presented in Table 3; the most common were accreta (38%) and atony (34%). Of all women who underwent cesarean delivery and carried these diagnoses, only a proportion required hysterectomy. Of the total cohort, approximately 71% (n=72) of total accreta cases and approximately 4% (n=81) of total atony required hysterectomy. Of the hysterectomy cases with a diagnosis recorded as accreta, 18% accompanied a primary cesarean delivery, whereas 82% had a prior procedure (P<.001). Of the hysterectomy cases with atony recorded as a diagnosis, 59% complicated primary cesarean delivery, whereas 41% had a prior cesarean delivery (P<.001). Overall, 32% of hysterectomy cases had a placenta previa, and 42 women (23%) had both previa and accreta as risk factors.
The majority of cases (66%) were total hysterectomies. Total hysterectomy was performed in 62% and 63% of the cases with a primary hysterectomy indication of accreta and atony, respectively. The median operative time was 154 minutes (interquartile range [IQR] 125–191) for all cases, and the median maternal length of stay was 5 days (IQR 4–9). Most women (n=105 or 57%) received general anesthesia, either from the outset or after initial use of regional anesthesia.
Complications observed in the hysterectomy cohort are listed in Table 4. Acute blood loss requiring transfusion was the most common complication. Overall, 84% of hysterectomy patients required transfusion. The mean (standard deviation) number of units of packed or whole red blood cells given intraoperatively was 4.6 (±5.4), whereas the average number of units given postoperatively was 3.7 (±4.0). The median change in hematocrit (from preoperative value to the lowest recorded postpartum) was 9.1% (IQR 4.8 to 13.9). Sixty-four (34%) patients required products beyond whole blood or packed red blood cells. Fresh frozen plasma was administered to 32% of patients, cryoprecipitate to 12%, and platelets to 15%. In addition, drain placement occurred in 22% of patients.
Measures to control hemorrhage and avoid hysterectomy, both medical and surgical, were employed in nearly two thirds of all hysterectomy cases before proceeding with definitive surgery. These included uterine artery ligation (48%), ovarian artery ligation (20%), uterine packing (6%), hypogastric artery ligation (5%), intramyometrial oxytocin injection (9%), and intrauterine warm saline infusion or the instillation of 400–500 mL of warm saline through a pressure catheter into the uterine cavity to treat uterine atony (14%).
Ureteral injury occurred in 3% of cases. Because of the potential for this type of injury, additional procedures were carried out to prevent or identify them. Of the 18 cystotomies, 13 were intentional. Ureteral stent placement occurred in 8% of patients, with intravenous administration of dye and bladder instillation of sterile milk occurring in 3% and 16% of patients, respectively. Accreta hysterectomy cases were more likely than atony hysterectomy cases to require ureteral stents (14% compared with 3%, P=.03) and to instill sterile milk into the bladder (23% compared with 8%, P=.02). Bowel injuries were identified in only two patients.
There were three maternal deaths among the 186 cases (1.6%). One death was due to cardiopulmonary arrest associated with sickle cell crisis, and the other two were attributed to amniotic fluid embolism. All three operations were repeat cesarean deliveries and the primary indications for hysterectomy in each case were accreta, atony, and disseminated intravascular coagulopathy.
We have confirmed in this large multicenter observational study that hysterectomy remains an uncommon, but not rare, complication of cesarean delivery, occurring in 0.5% of cesarean deliveries. Differences among centers with respect to frequency of this procedure, although not statistically significant (P=.12), may represent both differences in population characteristics or practice style or both. Our reported frequency of cesarean hysterectomy (4.7 per 1,000 cesarean deliveries) is somewhat lower than reported 10 to 20 years ago (7.0–8.3 per 1,000 cesarean deliveries).2,3 Current methods to control hemorrhage, including earlier treatment of uterine atony with prostaglandin agents and increased use of selective uterine arterial embolization, may have contributed to this reduction. Only 4% of all atony cases had a hysterectomy, whereas 71% of accreta cases had a hysterectomy.
Prior studies have indicated that hysterectomy after cesarean delivery is most often performed to control hemorrhage.2,3,5,14–18 The primary cause of hemorrhage has varied among these reports. In the 1990s, authors suggested an increasing contribution by accreta, particularly in association with a history previous cesarean deliveries and increasing with higher numbers of prior procedures.3,5,15,19 In contrast, three other contemporary studies reported uterine atony (56%) as the leading reason for cesarean hysterectomy.14,17,18 Maternal morbidity, including the risk for cesarean hysterectomy, in women with multiple repeat cesarean deliveries in this cohort has been reported.20 The risks of accreta and hysterectomy all directly increased with the number of cesarean deliveries.
In our study, accreta was the most common reason (38%) for hysterectomy, with atony being nearly as common (34%). With the decline in use of vaginal birth after cesarean in the past several years, accreta may rise in frequency as an indicator in the future. Other contemporary published reports had higher rates of accreta. For example, Stanco et al3 reported 50% of hysterectomy cases secondary to accreta during an era when fewer elective repeat operations were performed. The condition of accreta may have been underdiagnosed in our cohort due to several factors. The diagnosis of accreta was made clinically in our study; we did not have confirmatory pathology reports. Some cases of atony may have actually been complicated by focal areas of accreta leading to hemorrhage. Finally, we did not include women (n=28) who underwent postcesarean hysterectomy (laparotomy performed after the original procedure). Each of these may have altered the number of true accreta cases in either a positive or negative way.
Our study confirms that considerable morbidity can be expected after cesarean hysterectomy associated with both atony and accreta. This is in contrast to older studies, descriptions of predominantly elective or nonemergent procedures.4,8,9,11 Because the frequency of complications associated with nonemergent cesarean hysterectomy is comparatively low, some have advocated the option of elective cesarean hysterectomy in select cases.21 Direct comparison of elective compared with emergent cases in two studies demonstrated that elective cases clearly are associated with less blood loss and febrile morbidity and shorter operative times.22,23 Our cohort of hysterectomies at the time of cesarean delivery was not divided into elective compared with emergent cases. Some of the surgeries may have proceeded in a controlled, planned fashion more like the elective cases described elsewhere.
The most common morbidities of nonelective cesarean hysterectomy are transfusion of either red blood cells or other blood products. Our rate of transfusion (84%) is similar to other studies,3,5,23 as is the mean number of units transfused intraoperatively. We did note fewer cases of febrile morbidity (11%). This was significantly lower than other studies (31–50%)2,8,10; and may reflect the current use of prophylactic antibiotics in practice.
In summary, the rate of cesarean hysterectomy has declined modestly in the last decade. Despite the use of effective therapies and procedures to control hemorrhage at cesarean delivery, a small proportion of women continue to require hysterectomy to control hemorrhage from both uterine atony and placenta accreta. The present analysis may serve as a reference to health care providers and women in determining risk for cesarean hysterectomy and its attendant complications.
1. Depp R. Cesarean delivery. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 4th ed. New York (NY): Churchill Livingstone; 2002. p. 539–606.
2. Clark SL, Yeh SY, Phelan JP, Bruce S, Paul RH. Emergency hysterectomy for obstetric hemorrhage. Obstet Gynecol 1984;64:376–80.
3. Stanco LM, Schrimmer DB, Paul RH, Mishell DR Jr. Emergency peripartum hysterectomy and associated risk factors. Am J Obstet Gynecol 1993;168:879–83.
4. Chestnut DH, Eden RD, Gall SA, Parker RT. Peripartum hysterectomy: a review of cesarean and postpartum hysterectomy. Obstet Gynecol 1985;65:365–70.
5. Zelop CM, Harlow BL, Frigoletto FD Jr, Safon LE, Saltzman DH. Emergency peripartum hysterectomy. Am J Obstet Gynecol 1993;168:1443–8.
6. Plauché WC. Cesarean hysterectomy: indications, techniques, and complications. Clin Obstet Gynecol 1986;29:318–28.
7. Pelosi M, Langer A, Hung C. Prophylactic internal iliac artery ligation at cesarean hysterectomy. Am J Obstet Gynecol 1975;121:394–8.
8. Barclay DL, Hawks BL, Frueh DM, Power JD, Struble RH. Elective cesarean hysterectomy: a 5 year comparison with cesarean section. Am J Obstet Gynecol 1976;124:900–11.
9. Haynes DM, Martin BJ Jr. Cesarean hysterectomy: a twenty-five-year review. Am J Obstet Gynecol 1979;134:393–8.
10. Plauché WC, Gruich FG, Bourgeois MO. Hysterectomy at the time of cesarean section: analysis of 108 cases. Obstet Gynecol 1981;58:459–64.
11. McNulty JV. Elective cesarean hysterectomy—revisited. Am J Obstet Gynecol 1984;149:29–30.
12. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–48.
13. Casella G. Refining binomial confidence intervals. Can J Stat 1986;14:113–29.
14. Forna F, Miles AM, Jamieson DJ. Emergency peripartum hysterectomy: a comparison of cesarean and postpartum hysterectomy. Am J Obstet Gynecol 2004;190:1440–4.
15. Kastner ES, Figueroa R, Garry D, Maulik D. Emergency peripartum hysterectomy: experience at a community teaching hospital. Obstet Gynecol 2002;99:971–5.
16. Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985;66:89–92.
17. Wingprawat S, Chittacharoen A, Suthutvoravut S. Risk factors for emergency peripartum cesarean hysterectomy. Int J Gynaecol Obstet 2005;90:136–7.
18. Knight M, Kurinczuk JJ, Spark P, Brocklehurst P. Cesarean delivery and peripartum hysterectomy. Obstet Gynecol 2008;111:97–105.
19. Whiteman MK, Kuklina E, Hillis SD, Jamieson DJ, Meikle SF, Posner SF, et al. Incidence and determinants of peripartum hysterectomy. Obstet Gynecol 2006;108:1486–92.
20. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226–32.
21. Seago DP, Roberts WE, Johnson VK, Martin RW, Morrison JC, Martin JN Jr. Planned cesarean hysterectomy: a preferred alternative to separate operations. Am J Obstet Gynecol 1999;180:1385–93.
22. Gonsoulin W, Kennedy RT, Guidry KH. Elective versus emergency cesarean hysterectomy cases in a residency program setting: a review of 129 cases from 1984 to 1988. Am J Obstet Gynecol 1991;165:91–4.
23. Briery CM, Rose CH, Hudson WT, Lutgendorf MA, Magann EF, Chauhan SP, et al. Planned vs emergent cesarean hysterectomy. Am J Obstet Gynecol 2007;197:154.e1–5.
Supplemental Digital Content
© 2009 The American College of Obstetricians and Gynecologists